{"transactions":[{"id":2189501,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T20:50:49.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":7916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":125416,"derivative":{"exercise_price":10.395,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":7916},"source":{"system":"sec-edgar","filing":"0001209191-22-045230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122045230/doc4.xml","form_type":"4"}},{"id":2189500,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T20:50:49.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":70177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":140328,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":70177},"source":{"system":"sec-edgar","filing":"0001209191-22-045230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122045230/doc4.xml","form_type":"4"}},{"id":2189499,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-08-10T20:50:49.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":7916,"price":10.395,"value":82286.82,"ownership":{"direct":true},"balance_after":262500,"source":{"system":"sec-edgar","filing":"0001209191-22-045230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122045230/doc4.xml","form_type":"4"}},{"id":2189498,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-08-10T20:50:49.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":70177,"price":1.53,"value":107370.81,"ownership":{"direct":true},"balance_after":254584,"source":{"system":"sec-edgar","filing":"0001209191-22-045230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122045230/doc4.xml","form_type":"4"}},{"id":2337654,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:04:20.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":210505,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-018153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122018153/doc4.xml","form_type":"4"}},{"id":2337653,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-03-11T21:04:20.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":9000,"price":1.53,"value":13770.0,"ownership":{"direct":true},"balance_after":184407,"source":{"system":"sec-edgar","filing":"0001209191-22-018153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122018153/doc4.xml","form_type":"4"}},{"id":2374902,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T02:30:48.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":70000,"derivative":{"exercise_price":29.48,"expiration_date":"2032-02-21","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-22-012952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012952/doc4.xml","form_type":"4"}},{"id":2374901,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T02:30:48.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":219505,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-22-012952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012952/doc4.xml","form_type":"4"}},{"id":2374900,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-25T02:30:48.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":1375,"price":30,"value":41250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":175407,"source":{"system":"sec-edgar","filing":"0001209191-22-012952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012952/doc4.xml","form_type":"4"}},{"id":2374899,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-25T02:30:48.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":176782,"source":{"system":"sec-edgar","filing":"0001209191-22-012952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012952/doc4.xml","form_type":"4"}},{"id":2374898,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-25T02:30:48.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":175407,"source":{"system":"sec-edgar","filing":"0001209191-22-012952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012952/doc4.xml","form_type":"4"}},{"id":2382308,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-22T22:02:04.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":2293,"price":31.9309,"value":73217.5537,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":105407,"source":{"system":"sec-edgar","filing":"0001209191-22-011755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011755/doc4.xml","form_type":"4"}},{"id":2406464,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-09T23:58:43.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":220880,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-22-008208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122008208/doc4.xml","form_type":"4"}},{"id":2406463,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-09T23:58:43.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":1375,"price":33.94,"value":46667.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-22-008208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122008208/doc4.xml","form_type":"4"}},{"id":2406462,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-02-09T23:58:43.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-22-008208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122008208/doc4.xml","form_type":"4"}},{"id":2425236,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T00:35:06.000Z","date":"2022-01-25","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":222255,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-22-005117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122005117/doc4.xml","form_type":"4"}},{"id":2425235,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-01-27T00:35:06.000Z","date":"2022-01-25","kind":"sale","acquired":false,"shares":1375,"price":32.46,"value":44632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-22-005117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122005117/doc4.xml","form_type":"4"}},{"id":2425234,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-01-27T00:35:06.000Z","date":"2022-01-25","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-22-005117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122005117/doc4.xml","form_type":"4"}},{"id":2436019,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T21:09:41.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":223630,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-22-003175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122003175/doc4.xml","form_type":"4"}},{"id":2436018,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-01-13T21:09:41.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":1375,"price":35.1,"value":48262.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-22-003175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122003175/doc4.xml","form_type":"4"}},{"id":2436017,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2022-01-13T21:09:41.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-22-003175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122003175/doc4.xml","form_type":"4"}},{"id":2456205,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-30T22:00:10.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":225005,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-071611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121071611/doc4.xml","form_type":"4"}},{"id":2456204,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-30T22:00:10.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":1375,"price":39.95,"value":54931.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-071611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121071611/doc4.xml","form_type":"4"}},{"id":2456203,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-30T22:00:10.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-071611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121071611/doc4.xml","form_type":"4"}},{"id":2469941,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":226380,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2469940,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":229130,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2469939,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":2750,"price":50,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2469938,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":2750,"price":1.53,"value":4207.5,"ownership":{"direct":true},"balance_after":110450,"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2469937,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":1375,"price":45.88,"value":63085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2469936,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-16T22:04:44.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-069994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121069994/doc4.xml","form_type":"4"}},{"id":2488818,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-02T22:12:52.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":15125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":230505,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":15125},"source":{"system":"sec-edgar","filing":"0001209191-21-067659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067659/doc4.xml","form_type":"4"}},{"id":2488817,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-02T22:12:52.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":13750,"price":50,"value":687500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-067659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067659/doc4.xml","form_type":"4"}},{"id":2488816,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-02T22:12:52.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":1375,"price":45.6,"value":62700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":121450,"source":{"system":"sec-edgar","filing":"0001209191-21-067659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067659/doc4.xml","form_type":"4"}},{"id":2488815,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-12-02T22:12:52.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":15125,"price":1.53,"value":23141.25,"ownership":{"direct":true},"balance_after":122825,"source":{"system":"sec-edgar","filing":"0001209191-21-067659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067659/doc4.xml","form_type":"4"}},{"id":2504939,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T23:51:10.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":245630,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-065618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065618/doc4.xml","form_type":"4"}},{"id":2504938,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T23:51:10.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":1375,"price":32.67,"value":44921.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-065618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065618/doc4.xml","form_type":"4"}},{"id":2504937,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-11-18T23:51:10.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-065618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065618/doc4.xml","form_type":"4"}},{"id":2526414,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-03T20:33:01.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":247005,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-062707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121062707/doc4.xml","form_type":"4"}},{"id":2526413,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-11-03T20:33:01.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":1375,"price":36.94,"value":50792.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-062707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121062707/doc4.xml","form_type":"4"}},{"id":2526412,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-11-03T20:33:01.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-062707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121062707/doc4.xml","form_type":"4"}},{"id":2537366,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-21T21:00:28.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":248380,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-061274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121061274/doc4.xml","form_type":"4"}},{"id":2537365,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-10-21T21:00:28.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":1375,"price":38.87,"value":53446.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-061274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121061274/doc4.xml","form_type":"4"}},{"id":2537364,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-10-21T21:00:28.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-061274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121061274/doc4.xml","form_type":"4"}},{"id":2547212,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T22:26:45.000Z","date":"2021-10-05","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":249755,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-059853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121059853/doc4.xml","form_type":"4"}},{"id":2547211,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-10-06T22:26:45.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":1375,"price":33.75,"value":46406.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-059853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121059853/doc4.xml","form_type":"4"}},{"id":2547210,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-10-06T22:26:45.000Z","date":"2021-10-05","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":109075,"source":{"system":"sec-edgar","filing":"0001209191-21-059853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121059853/doc4.xml","form_type":"4"}},{"id":2559907,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-24T21:00:18.000Z","date":"2021-09-22","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":251130,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-21-057641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121057641/doc4.xml","form_type":"4"}},{"id":2559906,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-24T21:00:18.000Z","date":"2021-09-22","kind":"exercise","acquired":true,"shares":8000,"price":1.53,"value":12240.0,"ownership":{"direct":true},"balance_after":107700,"source":{"system":"sec-edgar","filing":"0001209191-21-057641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121057641/doc4.xml","form_type":"4"}},{"id":2562037,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-22T23:34:42.000Z","date":"2021-09-21","kind":"exercise","acquired":false,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":259130,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-057317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121057317/doc4.xml","form_type":"4"}},{"id":2562036,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-22T23:34:42.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":4125,"price":50,"value":206250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-057317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121057317/doc4.xml","form_type":"4"}},{"id":2562035,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-22T23:34:42.000Z","date":"2021-09-21","kind":"exercise","acquired":true,"shares":4125,"price":1.53,"value":6311.25,"ownership":{"direct":true},"balance_after":103825,"source":{"system":"sec-edgar","filing":"0001209191-21-057317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121057317/doc4.xml","form_type":"4"}},{"id":2574838,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T20:59:58.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":263255,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-055311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121055311/doc4.xml","form_type":"4"}},{"id":2574837,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-09T20:59:58.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":2750,"price":50,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-055311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121055311/doc4.xml","form_type":"4"}},{"id":2574836,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-09T20:59:58.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":1375,"price":49,"value":67375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":102450,"source":{"system":"sec-edgar","filing":"0001209191-21-055311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121055311/doc4.xml","form_type":"4"}},{"id":2574835,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-09-09T20:59:58.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":4125,"price":1.53,"value":6311.25,"ownership":{"direct":true},"balance_after":103825,"source":{"system":"sec-edgar","filing":"0001209191-21-055311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121055311/doc4.xml","form_type":"4"}},{"id":2589591,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-27T00:46:37.000Z","date":"2021-08-25","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":267380,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-21-053560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053560/doc4.xml","form_type":"4"}},{"id":2589590,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-27T00:46:37.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":2750,"price":50,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-053560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053560/doc4.xml","form_type":"4"}},{"id":2589589,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-27T00:46:37.000Z","date":"2021-08-25","kind":"exercise","acquired":true,"shares":2750,"price":1.53,"value":4207.5,"ownership":{"direct":true},"balance_after":102450,"source":{"system":"sec-edgar","filing":"0001209191-21-053560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053560/doc4.xml","form_type":"4"}},{"id":2590907,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-25T21:00:49.000Z","date":"2021-08-24","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":270130,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-053331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053331/doc4.xml","form_type":"4"}},{"id":2590906,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-25T21:00:49.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":1375,"price":48,"value":66000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-053331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053331/doc4.xml","form_type":"4"}},{"id":2590905,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-25T21:00:49.000Z","date":"2021-08-24","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-21-053331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053331/doc4.xml","form_type":"4"}},{"id":2592378,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-24T22:44:05.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":271505,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-21-053236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053236/doc4.xml","form_type":"4"}},{"id":2592377,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-24T22:44:05.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":13750,"price":50,"value":687500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-053236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053236/doc4.xml","form_type":"4"}},{"id":2592376,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-24T22:44:05.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":13750,"price":1.53,"value":21037.5,"ownership":{"direct":true},"balance_after":113450,"source":{"system":"sec-edgar","filing":"0001209191-21-053236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121053236/doc4.xml","form_type":"4"}},{"id":2606933,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-11T21:00:51.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":285255,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-050905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050905/doc4.xml","form_type":"4"}},{"id":2606932,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-11T21:00:51.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":1375,"price":41,"value":56375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-050905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050905/doc4.xml","form_type":"4"}},{"id":2606931,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-08-11T21:00:51.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-21-050905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050905/doc4.xml","form_type":"4"}},{"id":2623051,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-28T23:34:47.000Z","date":"2021-07-27","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":286630,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-048466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121048466/doc4.xml","form_type":"4"}},{"id":2623050,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-07-28T23:34:47.000Z","date":"2021-07-27","kind":"sale","acquired":false,"shares":1375,"price":36.72,"value":50490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-048466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121048466/doc4.xml","form_type":"4"}},{"id":2623049,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-07-28T23:34:47.000Z","date":"2021-07-27","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-21-048466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121048466/doc4.xml","form_type":"4"}},{"id":2634079,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-14T21:46:08.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":288005,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-046688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046688/doc4.xml","form_type":"4"}},{"id":2634078,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-07-14T21:46:08.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":1375,"price":36.72,"value":50490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-046688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046688/doc4.xml","form_type":"4"}},{"id":2634077,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-07-14T21:46:08.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-21-046688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046688/doc4.xml","form_type":"4"}},{"id":2650163,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T23:59:25.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":289380,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-044166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121044166/doc4.xml","form_type":"4"}},{"id":2650162,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-30T23:59:25.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":1375,"price":46.63,"value":64116.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-044166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121044166/doc4.xml","form_type":"4"}},{"id":2650161,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-30T23:59:25.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":101075,"source":{"system":"sec-edgar","filing":"0001209191-21-044166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121044166/doc4.xml","form_type":"4"}},{"id":2655895,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T20:36:05.000Z","date":"2021-06-23","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":290755,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-21-043032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121043032/doc4.xml","form_type":"4"}},{"id":2655894,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-24T20:36:05.000Z","date":"2021-06-23","kind":"exercise","acquired":true,"shares":8000,"price":1.53,"value":12240.0,"ownership":{"direct":true},"balance_after":99700,"source":{"system":"sec-edgar","filing":"0001209191-21-043032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121043032/doc4.xml","form_type":"4"}},{"id":2663925,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:03:53.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":298755,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-041514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041514/doc4.xml","form_type":"4"}},{"id":2663924,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-17T21:03:53.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":1375,"price":45.29,"value":62273.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-041514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041514/doc4.xml","form_type":"4"}},{"id":2663923,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-17T21:03:53.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":93075,"source":{"system":"sec-edgar","filing":"0001209191-21-041514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041514/doc4.xml","form_type":"4"}},{"id":2686681,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T21:38:30.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":300130,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-037342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037342/doc4.xml","form_type":"4"}},{"id":2686680,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-02T21:38:30.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1375,"price":42.51,"value":58451.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-037342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037342/doc4.xml","form_type":"4"}},{"id":2686679,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-06-02T21:38:30.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":93075,"source":{"system":"sec-edgar","filing":"0001209191-21-037342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037342/doc4.xml","form_type":"4"}},{"id":2705584,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-19T20:39:18.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":301505,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-034017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121034017/doc4.xml","form_type":"4"}},{"id":2705583,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-05-19T20:39:18.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":1375,"price":45.03,"value":61916.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-034017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121034017/doc4.xml","form_type":"4"}},{"id":2705582,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-05-19T20:39:18.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":93075,"source":{"system":"sec-edgar","filing":"0001209191-21-034017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121034017/doc4.xml","form_type":"4"}},{"id":2727389,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-05T23:36:03.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":1375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":302880,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":1375},"source":{"system":"sec-edgar","filing":"0001209191-21-030485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121030485/doc4.xml","form_type":"4"}},{"id":2727388,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-05-05T23:36:03.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":1375,"price":46.03,"value":63291.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-030485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121030485/doc4.xml","form_type":"4"}},{"id":2727387,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-05-05T23:36:03.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":1375,"price":1.53,"value":2103.75,"ownership":{"direct":true},"balance_after":93075,"source":{"system":"sec-edgar","filing":"0001209191-21-030485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121030485/doc4.xml","form_type":"4"}},{"id":2737286,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-28T20:41:50.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":304255,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001209191-21-028811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121028811/doc4.xml","form_type":"4"}},{"id":2737285,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-28T20:41:50.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":7900,"price":49.5034,"value":391076.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.4546 to $49.5295 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121028811/doc4.xml","form_type":"4"}},{"id":2737284,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-28T20:41:50.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":7900,"price":1.53,"value":12087.0,"ownership":{"direct":true},"balance_after":99600,"source":{"system":"sec-edgar","filing":"0001209191-21-028811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121028811/doc4.xml","form_type":"4"}},{"id":2744031,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T22:18:20.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":2340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":312155,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":2340},"source":{"system":"sec-edgar","filing":"0001209191-21-027614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121027614/doc4.xml","form_type":"4"}},{"id":2744030,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-20T22:18:20.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":2340,"price":48,"value":112320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-027614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121027614/doc4.xml","form_type":"4"}},{"id":2744029,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-20T22:18:20.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":2340,"price":1.53,"value":3580.2,"ownership":{"direct":true},"balance_after":94040,"source":{"system":"sec-edgar","filing":"0001209191-21-027614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121027614/doc4.xml","form_type":"4"}},{"id":2745204,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T00:00:55.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":314495,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-21-027425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121027425/doc4.xml","form_type":"4"}},{"id":2745203,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-20T00:00:55.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":3500,"price":1.53,"value":5355.0,"ownership":{"direct":true},"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001209191-21-027425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121027425/doc4.xml","form_type":"4"}},{"id":2748674,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-15T21:36:11.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":5560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":317995,"derivative":{"exercise_price":1.53,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":5560},"source":{"system":"sec-edgar","filing":"0001209191-21-026858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121026858/doc4.xml","form_type":"4"}},{"id":2748673,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":124713,"kind":"person","name":"Virgin Herbert","position":1,"cik":"0001786378","reported_name":"Virgin Herbert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2021-04-15T21:36:11.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":5560,"price":43.5691,"value":242244.196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.5286 to $43.6146 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":88200,"source":{"system":"sec-edgar","filing":"0001209191-21-026858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121026858/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-15T21:36:11.000000Z,2748673"}